Allogeneic haematopoietic stem cell transplantation in children with acute lymphoblastic leukaemia: The BFM/IBFM/EBMT concepts

BFM Study Group, the IBFM-Study Group and the Paediatric Disease Working Party of the EBMT

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Abstract

Children with high risk or relapsed acute lymphoblastic leukaemia (ALL) can benefit from allogeneic haematopoietic stem cell transplantation (SCT). To reduce transplantation-associated complications, the BFM study group, the IBFM study group and the PD-WP-EBMT initiated a prospective cooperative multicentre trail for paediatric ALL patients with an indication for allogeneic stem cell transplantation. Four-digit high-resolution HLA typing for all nonsibling donors, standardised GvHD prophylaxis and therapy, uniform conditioning regimen and minimum standards for supportive care should reduce not only treatment-related mortality but also ameliorate late effects for young patients. Furthermore, the prospective evaluation aims to assess the role of haematopoietic SCT in comparison to chemotherapy to enable valuable treatment recommendations for further decisions.

Original languageEnglish
Pages (from-to)S9-S11
JournalBone Marrow Transplantation
Volume35
DOIs
StatePublished - Mar 2005
Externally publishedYes

Keywords

  • Acute lymphoblastic leukaemia
  • Children
  • Conditioning
  • Donor
  • Stem cell transplantation

Fingerprint

Dive into the research topics of 'Allogeneic haematopoietic stem cell transplantation in children with acute lymphoblastic leukaemia: The BFM/IBFM/EBMT concepts'. Together they form a unique fingerprint.

Cite this